Founded with a mission to eliminate long-term handicaps from brain injuries, BrainSpace collaborates with physicians, families, financial backers, and other stakeholders. The company focuses on modernizing neurocritical care and cerebrospinal fluid (CSF) management through automation and data generation. Their flagship product is an automated CSF manager that provides precise, single-drop drainage control while maintaining the gravity-based methods trusted by neurosurgeons. This innovation aims to protect the brain after injury, stroke, or surgery by effectively managing intracranial pressure.

BrainSpace has garnered attention and support from notable investors and medical professionals committed to advancing neurocritical care. Their achievements include developing a groundbreaking automated CSF management system that has the potential to significantly improve patient outcomes. By integrating advanced technology with traditional practices, BrainSpace is poised to make a substantial impact on the treatment and recovery of brain injury patients, ultimately aiming to reduce long-term disabilities and enhance quality of life.